Pressmeddelande

Curasight to present at Redeye Fight Cancer Seminar

Cision Publicerad: 16 Jan 2023 11:03

Copenhagen, Denmark, 16 January 2023 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) hereby announces that CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær will present the company at Redeye Fight Cancer Seminar Outlook - January 19, 2023.

The presentation will include an update on the momentum and business progress made by the company and look ahead at the coming news flow for the new year. Management will give an overall update on the company’s pipeline based on the proprietary uPAR theranostics platform and focused on diagnosing and treating brain and prostate cancer.

The presentation will be webcasted live 15:05-15:25 (CET), Thursday January 19, 2023.

For more information – please click here

Bifogade filer

Press Release 16-01-2023https://mb.cision.com/Main/19744/3698082/1781746.pdf

Nyheter om Curasight

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!